These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Use of Magnetic Resonance Imaging for N-Staging in Patients with Non-Small Cell Lung Cancer. A Systematic Review. Brea TP; Raviña AR; Villamor JMC; Gómez AG; de Alegría AM; Valdés L Arch Bronconeumol (Engl Ed); 2019 Jan; 55(1):9-16. PubMed ID: 29803524 [TBL] [Abstract][Full Text] [Related]
6. The lung cancers: staging and response, CT, Owens C; Hindocha S; Lee R; Millard T; Sharma B Br J Radiol; 2023 Aug; 96(1148):20220339. PubMed ID: 37097296 [TBL] [Abstract][Full Text] [Related]
7. Head-to-head comparison of Zhang M; Liu Z; Yuan Y; Yang W; Cao X; Ma M; Han B Diagn Interv Radiol; 2024 Mar; 30(2):99-106. PubMed ID: 38291975 [TBL] [Abstract][Full Text] [Related]
8. Prospective comparison of Kirchner J; Sawicki LM; Nensa F; Schaarschmidt BM; Reis H; Ingenwerth M; Bogner S; Aigner C; Buchbender C; Umutlu L; Antoch G; Herrmann K; Heusch P Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):437-445. PubMed ID: 30074073 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic impact of integrated 18F-FDG PET/MRI in cerebral staging of patients with non-small cell lung cancer. Deuschl C; Nensa F; Grueneisen J; Poeppel TD; Sawicki LM; Heusch P; Gramsch C; Mönninghoff C; Quick HH; Forsting M; Umutlu L; Schlamann M Acta Radiol; 2017 Aug; 58(8):991-996. PubMed ID: 28273734 [TBL] [Abstract][Full Text] [Related]
10. An initial study on the comparison of diagnostic performance of Wang ML; Zhang H; Yu HJ; Tan H; Hu LZ; Kong HJ; Mao WJ; Xiao J; Shi HC Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(1):16-23. PubMed ID: 36243657 [TBL] [Abstract][Full Text] [Related]
11. Utility of FDG PET/CT for Preoperative Staging of Non-Small Cell Lung Cancers Manifesting as Subsolid Nodules With a Solid Portion of 3 cm or Smaller. Suh YJ; Park CM; Han K; Jeon SK; Kim H; Hwang EJ; Lee JH; Paeng JC; Lee CH; Kim YT; Goo JM AJR Am J Roentgenol; 2020 Mar; 214(3):514-523. PubMed ID: 31846374 [No Abstract] [Full Text] [Related]
12. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients. Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912 [TBL] [Abstract][Full Text] [Related]
14. Dual-time point 18F-FDG PET/CT scan for differentiation between 18F-FDG-avid non-small cell lung cancer and benign lesions. Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N Ann Nucl Med; 2009 Jul; 23(5):427-35. PubMed ID: 19437097 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Outcome of Lung Nodules Missed on 18F-FDG PET/MRI Compared with 18F-FDG PET/CT in Patients with Known Malignancies. Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Umutlu L; Antoch G; Heusch P J Nucl Med; 2016 Jan; 57(1):15-20. PubMed ID: 26514173 [TBL] [Abstract][Full Text] [Related]
16. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer. Shigemoto Y; Suga K; Matsunaga N Ann Nucl Med; 2016 May; 30(4):287-97. PubMed ID: 27007128 [TBL] [Abstract][Full Text] [Related]
17. Outcome of small lung nodules missed on hybrid PET/MRI in patients with primary malignancy. Raad RA; Friedman KP; Heacock L; Ponzo F; Melsaether A; Chandarana H J Magn Reson Imaging; 2016 Feb; 43(2):504-11. PubMed ID: 26192731 [TBL] [Abstract][Full Text] [Related]
18. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer. Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985 [TBL] [Abstract][Full Text] [Related]
19. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT. Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054 [TBL] [Abstract][Full Text] [Related]
20. Consistency and prognostic value of preoperative staging and postoperative pathological staging using Kajiyama A; Ito K; Watanabe H; Mizumura S; Watanabe SI; Yatabe Y; Gomi T; Kusumoto M Ann Nucl Med; 2022 Dec; 36(12):1059-1072. PubMed ID: 36264439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]